| JYSB2200065 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-04-08 | | Novo Nordisk A/S | | | view |
| JXSS2200005 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.1) | Import Drug Application | 2022-01-26 | | Octapharma Ab Sweden;Sichuan Sinco Pharmaceutical Co Ltd | | | view |
| JYSB2101162 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-11-10 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JYSB2300183 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2023-10-26 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JYSB2200143 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-08 | | Bayer Healthcare LLC | | | view |
| JYSB2400181 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-08-14 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JYSB2200093 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-09 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
| JYSB2400049 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-03-07 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| CXSS2200014 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2022-02-18 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| JYSB2400248 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-12-04 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JYSB2101081 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-07-05 | | Bayer Healthcare LLC | | | view |
| JYSB2300035 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2023-02-23 | | Bayer Healthcare LLC | | | view |
| JYSB1200214 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2012-08-27 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd;Bayer Healthcare LLC | Approval Completed-Pending Certificated | | view |
| CYSB2400134 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2024-05-24 | | SinoCelltech Ltd | | | view |
| JYSB2200092 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-09 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
| JYSB2500024 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-02-08 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
| JYSB2200164 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-24 | | Bayer Healthcare LLC | | | view |
| JYSB2200095 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-09 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
| JYSB2500083 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-03-26 | | Bayer Healthcare LLC | | | view |
| JYSZ2200030 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2022-06-29 | | Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd | | | view |
